On Dec 11, the latest report "Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market 2026 by Manufacturers, Regions, Types and Applications, Forecast to 2032" from Global Info Research provides a detailed and comprehensive analysis of the global Chlorhexidine Gluconate Product for Patient Skin Antisepsis market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand trends, and key factors that are causing many market demand changes. The report also provides company profiles and product examples of some of the competitors, as well as market share estimates for some of the leading players in 2026.
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/3391748/chlorhexidine-gluconate-product-for-patient-skin-antisepsis
According to our (Global Info Research) latest study, the global Chlorhexidine Gluconate Product for Patient Skin Antisepsis market size was valued at US$ 682 million in 2025 and is forecast to a readjusted size of USD million by 2032 with a CAGR of % during review period.
Chlorhexidine Gluconate (CHG) products for patient skin antisepsis are medical-grade antiseptic product specifically formulated to disinfect and cleanse the skin, thereby reducing the presence of harmful microorganisms. These products are widely used in healthcare settings for various purposes, including preoperative skin preparation and routine patient hygiene.
Chlorhexidine gluconate (CHG) products are specially formulated for disinfection and cleaning of the skin, which can effectively reduce the presence of harmful microorganisms. They are widely used for preoperative skin preparation and routine patient hygiene. Common product types include solutions, washes, wipes, shampoo caps, brushes, applicators, etc.
Chlorhexidine gluconate has a killing effect on Gram-positive and Gram-negative bacteria, facultative anaerobes, aerobic bacteria and yeasts. It is particularly effective against Gram-positive bacteria. With the advent of an aging population, the number of surgeries worldwide has increased year by year. According to statistics, more than 300 million people undergo surgical operations worldwide each year, and surgical site infections (SSIs) and the wounds they cause are also increasing. It refers to nosocomial infections secondary to surgery that occur at or near the surgical incision, deep organs or cavities. It is one of the serious complications after modern surgery and orthopedics, a common cause of unplanned readmissions, and a global problem. SSI patients account for 2% to 5% of hospitalized surgical patients, and the annual incidence rate varies. The number of SSI patients in the United States is 160,000 to 300,000 per year. Studies have shown that chlorhexidine is more advantageous than povidone-iodine in preventing total infection and superficial site infection after potentially contaminated surgery.
With the outbreak of COVID-19, chlorhexidine gluconate ushered in explosive growth in 2020-2021. From a global perspective, Europe and the United States are the core market areas for chlorhexidine gluconate (CHG) products, especially North America, which accounts for 43% of the revenue share, followed by Europe, which accounts for 35% of the market share. The Asia-Pacific region currently mainly uses povidone-iodine for preoperative skin disinfection, but with the continuous expansion of awareness of chlorhexidine gluconate products and the gradual deepening of market promotion, there will be huge market potential in the future.
There are many global players in the chlorhexidine gluconate market, with a wide variety of product types, but most of them are small in scale. The top five manufacturers are mainly European and American companies, namely BD, Ecolab, Stryker, Molnlycke, and Xttrium, which will account for more than 60% of the global market share in 2023. Among them, BD's ChloraPrep applicator products are the world's leading sales, with annual sales exceeding 150 million units. Product types have also gradually evolved from the initial solutions and lotions to wet wipes, gloves, brushes, shampoo caps, etc. Currently, lotions and solution products occupy the core market share.
Chlorhexidine gluconate products are widely used for patient skin disinfection to prevent infection, including hospital-acquired infections (HAIs) and surgical site infections (SSIs). With the increase in demand in surgical and preoperative environments and the increasing awareness of infection prevention, the overall market will continue to expand.
This report is a detailed and comprehensive analysis for global Chlorhexidine Gluconate Product for Patient Skin Antisepsis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
Chlorhexidine Gluconate Product for Patient Skin Antisepsis market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Antiseptic Wash Lotion & Solution、 Antiseptic Wipes & Gloves、 Antiseptic Caps、 Others
Market segment by Application: Operating Theatre、 Intensive Care Unit、 General Ward、 Others
Major players covered: BD、 Ecolab、 Stryker、 Molnlycke、 Xttrium、 3M、 B. Braun、 Medichem、 GAMA Healthcare、 PDI EMEA Ltd.、 Arion Deutschland GmbH、 Medline、 CV Médica、 Bajaj Medical LLC、 SC Johnson Professional、 Germo、 ACTO GmbH、 Lernapharm (LORIS)、 URGO Sp. z o.o.、 Welcare Industries、 Pearmine Health (Dymacare)、 Valderma、 Innopart Medpro、 Raman & Weil Science、 Microwin Labs、 Weigao Group、 Lionser、 ShanDong Mint Medical Technology、 KINGFA MEDICAL、 Shandong Retouch Wash and Sterilize Technology、 Liaoning Control Sensory Disinfection Technology、 Shandong Disineer Disinfection Science and Technology
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chlorhexidine Gluconate Product for Patient Skin Antisepsis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chlorhexidine Gluconate Product for Patient Skin Antisepsis, with price, sales quantity, revenue, and global market share of Chlorhexidine Gluconate Product for Patient Skin Antisepsis from 2021 to 2026.
Chapter 3, the Chlorhexidine Gluconate Product for Patient Skin Antisepsis competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chlorhexidine Gluconate Product for Patient Skin Antisepsis breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment Chlorhexidine Gluconate Product for Patient Skin Antisepsis the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the Chlorhexidine Gluconate Product for Patient Skin Antisepsis sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2025.and Chlorhexidine Gluconate Product for Patient Skin Antisepsis market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chlorhexidine Gluconate Product for Patient Skin Antisepsis.
Chapter 14 and 15, to describe Chlorhexidine Gluconate Product for Patient Skin Antisepsis sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chlorhexidine Gluconate Product for Patient Skin Antisepsis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
No comments:
Post a Comment